PARP Inhibitors: - AZN's Lynparz's CR= 2% vs CLVS's Ruca CR=9%. It is the 4.5x-difference in CLVS favor - AZN's Lynparz's ORR= 34% vs CLVS's Ruca ORR= 54%. This is a 1.6x-difference in CLVS favor - AZN's Lynparz's PFS=6.7 months vs CLVS's Ruca PFS=10 months. This is a 1.5x-difference in CLVS favor